Allworth Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $375K | Buy |
2,980
+2,845
| +2,107% | +$358K | ﹤0.01% | 923 |
|
|
2025
Q1 | $14.3K | Sell |
135
-31
| -19% | -$3.28K | ﹤0.01% | 2261 |
|
|
2024
Q4 | $24.4K | Buy |
166
+30
| +22% | +$4.4K | ﹤0.01% | 1964 |
|
|
2024
Q3 | $15.7K | Sell |
136
-98
| -42% | -$11.3K | ﹤0.01% | 2053 |
|
|
2024
Q2 | $34.1K | Buy |
234
+146
| +166% | +$21.3K | ﹤0.01% | 1559 |
|
|
2024
Q1 | $12.1K | Hold |
88
| – | – | ﹤0.01% | 2025 |
|
|
2023
Q4 | $11.6K | Buy |
88
+32
| +57% | +$4.22K | ﹤0.01% | 1924 |
|
|
2023
Q3 | $6.3K | Sell |
56
-19
| -25% | -$2.14K | ﹤0.01% | 2012 |
|
|
2023
Q2 | $7.07K | Sell |
75
-2
| -3% | -$189 | ﹤0.01% | 1971 |
|
|
2023
Q1 | $7.79K | Buy |
77
+25
| +48% | +$2.53K | ﹤0.01% | 1879 |
|
|
2022
Q4 | $6.21K | Sell |
52
-1
| -2% | -$119 | ﹤0.01% | 1824 |
|
|
2022
Q3 | $6K | Buy |
53
+25
| +89% | +$2.83K | ﹤0.01% | 1827 |
|
|
2022
Q2 | $3K | Buy |
28
+9
| +47% | +$964 | ﹤0.01% | 1914 |
|
|
2022
Q1 | $2K | Sell |
19
-88
| -82% | -$9.26K | ﹤0.01% | 1805 |
|
|
2021
Q4 | $9K | Sell |
107
-17
| -14% | -$1.43K | ﹤0.01% | 1410 |
|
|
2021
Q3 | $12K | Buy |
+124
| New | +$12K | ﹤0.01% | 1229 |
|